Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients.

Ravi A, Halstead FD, Bamford A, Casey A, Thomson NM, van Schaik W, Snelson C, Goulden R, Foster-Nyarko E, Savva GM, Whitehouse T, Pallen MJ, Oppenheim BA.

Microb Genom. 2019 Sep;5(9). doi: 10.1099/mgen.0.000293. Epub 2019 Sep 11.

2.

Violet-Blue Light Arrays at 405 Nanometers Exert Enhanced Antimicrobial Activity for Photodisinfection of Monomicrobial Nosocomial Biofilms.

Halstead FD, Hadis MA, Marley N, Brock K, Milward MR, Cooper PR, Oppenheim B, Palin WM.

Appl Environ Microbiol. 2019 Oct 16;85(21). pii: e01346-19. doi: 10.1128/AEM.01346-19. Print 2019 Nov 1.

3.

The potential of visible blue light (405 nm) as a novel decontamination strategy for carbapenemase-producing enterobacteriaceae (CPE).

Halstead FD, Ahmed Z, Bishop JRB, Oppenheim BA.

Antimicrob Resist Infect Control. 2019 Jan 17;8:14. doi: 10.1186/s13756-019-0470-1. eCollection 2019.

4.

Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.

Halstead FD, Ravi A, Thomson N, Nuur M, Hughes K, Brailey M, Oppenheim BA.

J Hosp Infect. 2019 Jun;102(2):125-134. doi: 10.1016/j.jhin.2018.10.012. Epub 2018 Oct 22.

PMID:
30359648
5.

Use of an engineered honey to eradicate preformed biofilms of important wound pathogens: an in vitro study.

Halstead FD, Webber MA, Oppenheim BA.

J Wound Care. 2017 Aug 2;26(8):442-450. doi: 10.12968/jowc.2017.26.8.442.

PMID:
28795889
6.

A systematic review of quantitative burn wound microbiology in the management of burns patients.

Halstead FD, Lee KC, Kwei J, Dretzke J, Oppenheim BA, Moiemen NS.

Burns. 2018 Feb;44(1):39-56. doi: 10.1016/j.burns.2017.06.008. Epub 2017 Aug 4.

PMID:
28784345
7.

Antibacterial Activity of Blue Light against Nosocomial Wound Pathogens Growing Planktonically and as Mature Biofilms.

Halstead FD, Thwaite JE, Burt R, Laws TR, Raguse M, Moeller R, Webber MA, Oppenheim BA.

Appl Environ Microbiol. 2016 Jun 13;82(13):4006-4016. doi: 10.1128/AEM.00756-16. Print 2016 Jul 1.

8.

Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.

Payne RO, Milne KH, Elias SC, Edwards NJ, Douglas AD, Brown RE, Silk SE, Biswas S, Miura K, Roberts R, Rampling TW, Venkatraman N, Hodgson SH, Labbé GM, Halstead FD, Poulton ID, Nugent FL, de Graaf H, Sukhtankar P, Williams NC, Ockenhouse CF, Kathcart AK, Qabar AN, Waters NC, Soisson LA, Birkett AJ, Cooke GS, Faust SN, Woods C, Ivinson K, McCarthy JS, Diggs CL, Vekemans J, Long CA, Hill AV, Lawrie AM, Dutta S, Draper SJ.

J Infect Dis. 2016 Jun 1;213(11):1743-51. doi: 10.1093/infdis/jiw039. Epub 2016 Feb 4. Erratum in: J Infect Dis. 2016 Sep 15;214(6):978.

9.

In vitro activity of an engineered honey, medical-grade honeys, and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates.

Halstead FD, Webber MA, Rauf M, Burt R, Dryden M, Oppenheim BA.

J Wound Care. 2016 Feb;25(2):93-4, 96-102. doi: 10.12968/jowc.2016.25.2.93.

PMID:
26878302
10.

Protocol for a systematic review of quantitative burn wound microbiology in the management of burns patients.

Kwei J, Halstead FD, Dretzke J, Oppenheim BA, Moiemen NS.

Syst Rev. 2015 Nov 6;4:150. doi: 10.1186/s13643-015-0137-9.

11.

The Antibacterial Activity of Acetic Acid against Biofilm-Producing Pathogens of Relevance to Burns Patients.

Halstead FD, Rauf M, Moiemen NS, Bamford A, Wearn CM, Fraise AP, Lund PA, Oppenheim BA, Webber MA.

PLoS One. 2015 Sep 9;10(9):e0136190. doi: 10.1371/journal.pone.0136190. eCollection 2015.

12.

Antimicrobial dressings: Comparison of the ability of a panel of dressings to prevent biofilm formation by key burn wound pathogens.

Halstead FD, Rauf M, Bamford A, Wearn CM, Bishop JRB, Burt R, Fraise AP, Moiemen NS, Oppenheim BA, Webber MA.

Burns. 2015 Dec;41(8):1683-1694. doi: 10.1016/j.burns.2015.06.005. Epub 2015 Jul 16.

PMID:
26188884
13.

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.

Biswas S, Choudhary P, Elias SC, Miura K, Milne KH, de Cassan SC, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Osier FH, Hodgson SH, Duncan CJ, O'Hara GA, Long CA, Hill AV, Draper SJ.

PLoS One. 2014 Sep 25;9(9):e107903. doi: 10.1371/journal.pone.0107903. eCollection 2014.

14.

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.

Elias SC, Choudhary P, de Cassan SC, Biswas S, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Hodgson SH, Duncan CJ, Hill AV, Draper SJ.

Immunology. 2014 Apr;141(4):628-44. doi: 10.1111/imm.12226.

15.

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation.

Ewer KJ, O'Hara GA, Duncan CJ, Collins KA, Sheehy SH, Reyes-Sandoval A, Goodman AL, Edwards NJ, Elias SC, Halstead FD, Longley RJ, Rowland R, Poulton ID, Draper SJ, Blagborough AM, Berrie E, Moyle S, Williams N, Siani L, Folgori A, Colloca S, Sinden RE, Lawrie AM, Cortese R, Gilbert SC, Nicosia A, Hill AV.

Nat Commun. 2013;4:2836. doi: 10.1038/ncomms3836.

16.

Universal extraction method for gastrointestinal pathogens.

Halstead FD, Lee AV, Couto-Parada X, Polley SD, Ling C, Jenkins C, Chalmers RM, Elwin K, Gray JJ, Iturriza-Gómara M, Wain J, Clark DA, Bolton FJ, Manuel RJ; Olympics GI Group.

J Med Microbiol. 2013 Oct;62(Pt 10):1535-9. doi: 10.1099/jmm.0.058743-0. Epub 2013 Jul 5.

PMID:
23831766
17.

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.

Elias SC, Collins KA, Halstead FD, Choudhary P, Bliss CM, Ewer KJ, Sheehy SH, Duncan CJ, Biswas S, Hill AV, Draper SJ.

J Immunol. 2013 Feb 1;190(3):1135-47. doi: 10.4049/jimmunol.1201455. Epub 2013 Jan 4.

18.

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.

Sheehy SH, Duncan CJ, Elias SC, Choudhary P, Biswas S, Halstead FD, Collins KA, Edwards NJ, Douglas AD, Anagnostou NA, Ewer KJ, Havelock T, Mahungu T, Bliss CM, Miura K, Poulton ID, Lillie PJ, Antrobus RD, Berrie E, Moyle S, Gantlett K, Colloca S, Cortese R, Long CA, Sinden RE, Gilbert SC, Lawrie AM, Doherty T, Faust SN, Nicosia A, Hill AV, Draper SJ.

Mol Ther. 2012 Dec;20(12):2355-68. doi: 10.1038/mt.2012.223. Epub 2012 Oct 23.

19.

An evaluation of the Mast D69C AmpC Detection Disc Set for the detection of inducible and derepressed AmpC β-lactamases.

Halstead FD, Vanstone GL, Balakrishnan I.

J Antimicrob Chemother. 2012 Sep;67(9):2303-4. doi: 10.1093/jac/dks170. Epub 2012 May 7. No abstract available.

PMID:
22566593
20.

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.

Sheehy SH, Duncan CJ, Elias SC, Biswas S, Collins KA, O'Hara GA, Halstead FD, Ewer KJ, Mahungu T, Spencer AJ, Miura K, Poulton ID, Dicks MD, Edwards NJ, Berrie E, Moyle S, Colloca S, Cortese R, Gantlett K, Long CA, Lawrie AM, Gilbert SC, Doherty T, Nicosia A, Hill AV, Draper SJ.

PLoS One. 2012;7(2):e31208. doi: 10.1371/journal.pone.0031208. Epub 2012 Feb 21.

21.

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.

O'Hara GA, Duncan CJ, Ewer KJ, Collins KA, Elias SC, Halstead FD, Goodman AL, Edwards NJ, Reyes-Sandoval A, Bird P, Rowland R, Sheehy SH, Poulton ID, Hutchings C, Todryk S, Andrews L, Folgori A, Berrie E, Moyle S, Nicosia A, Colloca S, Cortese R, Siani L, Lawrie AM, Gilbert SC, Hill AV.

J Infect Dis. 2012 Mar 1;205(5):772-81. doi: 10.1093/infdis/jir850. Epub 2012 Jan 24.

22.

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.

Sheehy SH, Duncan CJ, Elias SC, Collins KA, Ewer KJ, Spencer AJ, Williams AR, Halstead FD, Moretz SE, Miura K, Epp C, Dicks MD, Poulton ID, Lawrie AM, Berrie E, Moyle S, Long CA, Colloca S, Cortese R, Gilbert SC, Nicosia A, Hill AV, Draper SJ.

Mol Ther. 2011 Dec;19(12):2269-76. doi: 10.1038/mt.2011.176. Epub 2011 Aug 23.

23.

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.

Duncan CJ, Sheehy SH, Ewer KJ, Douglas AD, Collins KA, Halstead FD, Elias SC, Lillie PJ, Rausch K, Aebig J, Miura K, Edwards NJ, Poulton ID, Hunt-Cooke A, Porter DW, Thompson FM, Rowland R, Draper SJ, Gilbert SC, Fay MP, Long CA, Zhu D, Wu Y, Martin LB, Anderson CF, Lawrie AM, Hill AV, Ellis RD.

PLoS One. 2011;6(7):e22271. doi: 10.1371/journal.pone.0022271. Epub 2011 Jul 22.

24.

A molecular epidemiological investigation of Ascaris on Unguja, Zanzibar using isoenyzme analysis, DNA barcoding and microsatellite DNA profiling.

Betson M, Halstead FD, Nejsum P, Imison E, Khamis IS, Sousa-Figueiredo JC, Rollinson D, Stothard JR.

Trans R Soc Trop Med Hyg. 2011 Jul;105(7):370-9. doi: 10.1016/j.trstmh.2011.04.009. Epub 2011 May 24.

PMID:
21605883

Supplemental Content

Loading ...
Support Center